eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | neutropenia |
| Comorbidity | C0235974|pancreatic cancer |
| Sentences | 2 |
| PubMedID- 22024222 | Background/aim: factors predicting the appearance of neutropenia were evaluated in patients with advanced pancreatic cancer undergoing gemcitabine hydrochloride (gem) therapy. |
| PubMedID- 22133387 | The rrs of severe neutropenia were lowest in patients with pancreatic cancer treated with cetuximab compared with controls (rr 1.02; 95% ci 0.79, 1.31; fixed-effect model: and rr 1.06; 95% ci 0.72, 1.55; random-effects model), and highest in patients with squamous cell carcinoma of the esophagus (rr 1.64; 95% ci 0.53, 5.04; fixed-effect model: and rr 1.64; 95% ci 0.53, 5.04; random-effects model). |
Page: 1